SERVICIO ANDALUZ DE SALUD /HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO AND INSTITUTO DE BIOMEDICINA DE SEVILLA (SAS-HUVR-IBIS)
Department of Medical Oncology
The HUVR is a tertiary University hospital that act as a referral center for oncological diseases for the south of Spain (Almost 9 millions of inhabitants). The thoracic cancer multidisciplinary team has recognized experience in the treatment of lung cancer and mesothelioma. The campus includes an Biomedical research instituite (IBIS), with an extensive Cancer and Genetics Programs. Molecular taxonomy, biomarker discovery and new drug development in mesothelioma is one of main topics interest.
Key staff of the partner
Dr Luis Paz-Ares (MD, PhD),Chair of the Oncology Department (Hospital Universitario Virgen del Rocío), leader of the Cancer Program at the HUVR_IBIS. He is a medical oncologist devoted to patient care and research on thoracic malignancies (lung cancer, mesothelioma), recognised as a international expert on the field. Member of many cooperative groups and networks focusing in mesothelioma (IASLC, EORTC, RTICC and SLCG), he published over 150 publications in the context.
Victoria Villena (MD, PhD),pulmonologist expert in mesothelioma, pleural diseases- biomarkers/registry. She is one of the national leaders in this disease, and Chair of the Spanis Registry in mesothelioma of the Spanish Respiratory Diseases Society.
Francisco Rodriguez Panadero (MD, PHD), is Pulmonologist with particular interest, international recognition in pleural diseases (mesothelioma and other malignancies).
Fernando Lopez-Rios, Chair of the Pathology Dept. at the Campal Cancer Center. His areas of activity included thoracic pathology, lung cancer and mesothelioma. He is member of many cooperative groups with focus on Mesothelioma.
Rocio García-Carbonero (MD, PhD), Medical oncologist with interest in GI and thoracic cancers (peritoneal mesothelioma).
Jesus Corral (MD, PhD), Medical oncologist with expertise on the study of mesothelioma and lung cancer.
Sonia Molina-Pinelo (PhD), translational researcher with interest in molecular taxonomy-biomarker development of lung cancer and mesothelioma.